Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530003, China.
The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Sci Rep. 2020 Oct 20;10(1):17846. doi: 10.1038/s41598-020-74913-0.
In order to understand the clinical manifestations and incidence of gastrointestinal symptoms of coronavirus disease (COVID-19) in children and discuss the importance of fecal nucleic acid testing.We retrospectively analyzed studies on gastrointestinal symptoms and fecal nucleic acid detection in pediatric COVID-19 patients from January 1, 2020 to August 10, 2020, including prospective clinical studies and case reports. The results of fecal nucleic acid detection were analyzed systematically. Stata12.0 software was used for meta-analysis.The results showed that the most common gastrointestinal symptoms in children with COVID-19 were vomiting and diarrhea, with a total incidence of 17.7% (95% Cl 13.9-21.5%). However, the prevalence of gastrointestinal symptoms in other countries (21.1%, 95% CI 16.5-25.7%) was higher compared to China (12.9%, 95% CI 8-17.7%). In Wuhan, the pooled prevalence was much higher (41.3%, 95% CI 3.2-79.4%) compared to areas outside Wuhan in China (7.1%, 95% CI 4.0-10.3%). The positive rate of fecal nucleic acid testing in COVID-19 children was relatively high at 85.8% (91/106). Additionally, 71.2% (52/73) were still positive for fecal nucleic acid after respiratory tract specimens turned negative. One and two weeks after the respiratory tract specimens turned nucleic acid-negative, 45.2% (33/73) and 34.2% (25/73) patients, respectively, remained fecal nucleic acid-positive. The longest interval between the respiratory tract specimens turning negative and fecal specimens turning negative exceeded 70 days. Conclusions and relevance: gastrointestinal symptoms in pediatric COVID-19 are relatively common. Attention should be paid to the detection of fecal nucleic acids in children. Fecal nucleic acid-negative status should be considered as one of the desegregation standards.
为了了解儿童新型冠状病毒病(COVID-19)的临床症状和胃肠道症状的发生率,并探讨粪便核酸检测的重要性。我们对 2020 年 1 月 1 日至 2020 年 8 月 10 日期间儿童 COVID-19 患者胃肠道症状和粪便核酸检测的前瞻性临床研究和病例报告进行了回顾性分析。系统分析了粪便核酸检测结果。采用 Stata12.0 软件进行荟萃分析。结果显示,儿童 COVID-19 最常见的胃肠道症状为呕吐和腹泻,总发生率为 17.7%(95%Cl 13.9-21.5%)。然而,其他国家(21.1%,95%CI 16.5-25.7%)的胃肠道症状发生率高于中国(12.9%,95%CI 8-17.7%)。在武汉,其汇总患病率明显高于中国武汉以外地区(41.3%,95%CI 3.2-79.4%)(7.1%,95%CI 4.0-10.3%)。COVID-19 患儿粪便核酸检测阳性率相对较高,为 85.8%(91/106)。此外,呼吸道标本转为阴性后,仍有 71.2%(52/73)粪便核酸阳性。呼吸道标本转为核酸阴性后 1 周和 2 周,分别有 45.2%(33/73)和 34.2%(25/73)患者粪便核酸仍为阳性。呼吸道标本转为阴性与粪便标本转为阴性的最长间隔时间超过 70 天。结论和相关性:儿童 COVID-19 胃肠道症状较为常见。应重视儿童粪便核酸检测。粪便核酸阴性应作为解除隔离标准之一。